SCHEMBL7647484

SCHEMBL7647484

Cc1ccc(CN(C(CCC(=O)O)C(=O)O)[PH](=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
FFAR1 O14842 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
FOLH1 Q04609 3/20 0.34
PTGFR P43088 1/20 0.34
ALDH1A1 P00352 2/20 0.34
CPA3 P15088 1/20 0.34
KDM4E B2RXH2 1/20 0.34
TP53 P04637 1/20 0.34
GLA P06280 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
HPGD P15428 1/20 0.34
ALOX12 P18054 1/20 0.34
NFKB1 P19838 1/20 0.34
APEX1 P27695 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3380508 0.87 CPA3 (0.46) FFAR1FOLH1ALDH1A1CPA3KDM4E
SCHEMBL11488435 0.79 FFAR1 (0.44) KMT2AFFAR1L3MBTL1FOLH1ALDH1A1
SCHEMBL3384127 0.75 CYP1A2 (0.39) FOLH1
SCHEMBL7654496 0.74 EPOR (0.46) KMT2AFFAR1PTGFRMEN1
SCHEMBL3380552 0.73 HDAC1 (0.49) FFAR1FOLH1CPA3MAPK1
SCHEMBL3382538 0.72 CYP1A2 (0.37) FFAR1FOLH1HSD17B10
SCHEMBL3383403 0.71 AKR1B1 (0.38) KMT2AFFAR1ALDH1A1HSD17B10MEN1
SCHEMBL7645575 0.69 CYP1A2 (0.55) FFAR1CYP2D6
SCHEMBL7644621 0.69 FFAR1 (0.42) KMT2AFFAR1ALDH1A1CPA3
SCHEMBL28600697 0.69 TAS2R14 (0.44) ALDH1A1POLBCYP2D6MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372726-B1 ADMINISTERING CARBOXYALKYL PHOSPHONATE, PHOSPHORAMIDATE, OR PHOSPHINE OXIDE DERIVATIVE AS ANTITUMOR AGENT TO TREAT CANCER OF PROSTATE GLAND GUILFORD PHARMACEUTICALS INC. 2002-04-16 US disclosed